Both direct and indirect effects of leptin in regulating cancer proliferation, metastasis, angiogenesis, and chemoresistance have been identified [90], and leptin—either alone or in combination with other adipokines and cytokines—has been identified as a biomarker of cancer risk [91,92]. Here, LEP is linked to cancer.